Portfolio Company Headlines

May 12, 2017

Millipede Announces Successful First Use of the Iris Complete Annuloplasty Ring

March 24, 2017

Biostable Science & Engineering scores FDA nod for aortic valve repair device

March 17, 2017

Austin, TX
Threshold Pharmaceuticals and Molecular Templates Agree to Combine

March 6, 2017

FDA Advisory Committee Strongly Supports Granting De Novo Application for Claret TAVR Cerebral Protection System

February 1, 2017

TVA Medical – Everlinq Endoavf System as a viable alternative to surgical AVF procedures

October 28, 2016

New data on EndoStim® therapy for the treatment of gastro-esophageal reflux disease (GERD) presented at United European Gastroenterology Week 2016

September 20, 2016

Santa Rosa, CA
Claret Medical Announces SENTINEL Pivotal IDE Trial to Be Featured in Late-Breaking Trial Session at Transcatheter Cardiovascular Therapeutics (TCT) Conference

May 4, 2016

Goleta, CA
BAROnova Announces Appointment of David S. Thrower as President and Chief Executive Officer

April 7, 2016

Austin, TX
Lumos Pharma Raises $34 Million in Series B Financing

January 28, 2016

Santa Rosa, CA
Millipede’s Play In Percutaneous Mitral Valve Repair

January 11, 2016

Seattle, WA
Juno Therapeutics Adds Next-Generation Single Cell Sequencing Capabilities Through Acquisition of AbVitro

December 22, 2015

Santa Rosa, CA
Cerebral Embolic Protection For TAVR: Start-Ups Compete

December 11, 2015

Goleta, CA
BAROnova Announces Enrollment of First Patients in the ENDObesity II Pivotal Clinical Trial

November 23, 2015

Goleta, CA
BAROnova Closes $36.5 Million Series D Financing

October 20, 2015

St. Louis, MO
EndoStim receives CE Mark for full body MRI use with EndoStim II LES Stimulation System